All Stories

  1. Beyond significant wave height: A new approach for validating spectral wave models

    Article • Coastal Engineering, June 2015, Elsevier

    Rob Lambkin-Williams

  2. Virus-Specific Antibody Secreting Cell, Memory B-cell, and Sero-Antibody Responses in the Human Influenza Challenge Model

    Article • The Journal of Infectious Diseases, January 2014, Oxford University Press (OUP)

    Rob Lambkin-Williams

  3. Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals

    Article • Antiviral Therapy, January 2013, International Medical Press

    Rob Lambkin-Williams

  4. Poster #235 SMOKING AND OTHER CARDIOVASCULAR DISEASE RISK BEHAVIOURS AMONG PEOPLE WITH SEVERE MENTAL DISORDERS

    Article • Schizophrenia Research, April 2012, Elsevier

    Rob Lambkin-Williams

  5. A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity

    Article • Vaccine, March 2011, Elsevier

    Rob Lambkin-Williams

  6. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders

    Article • BMC Public Health, January 2011, Springer Science + Business Media

    Rob Lambkin-Williams

  7. Influenza Vaccines Have a Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic

    Article • September 2010, Springer Science + Business Media

    Rob Lambkin-Williams

  8. Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine

    Article • Vaccine, September 2010, Elsevier

    Rob Lambkin-Williams

  9. Inhaled Cationic Airway Lining Modulator (iCALM) Therapy, A Novel Aerosol Treatment For Respiratory Infections Reduces Clinical Symptoms And Transmission Of Influenza A Infection.

    Article • May 2010, American Thoracic Society

    Rob Lambkin-Williams

  10. Gene Expression Signatures Diagnose Influenza and Other Symptomatic Respiratory Viral Infections in Humans

    Article • Cell Host & Microbe, September 2009, Elsevier

    Rob Lambkin-Williams

  11. DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

    Article • Vaccine, April 2009, Elsevier

    Rob Lambkin-Williams

  12. Animal models in influenza vaccine testing

    Article • Expert Review of Vaccines, August 2008, Taylor & Francis

    Rob Lambkin-Williams

  13. A curious thing

    Article • BMJ, July 2008, BMJ

    Rob Lambkin-Williams

  14. Influenza vaccines have a short but illustrious history

    Article • January 2008, Springer Science + Business Media

    Rob Lambkin-Williams

  15. Virucidal Performance of Various Professional Hand Hygiene Products Against Avian Influenza A H5N1

    Article • American Journal of Infection Control, June 2007, Elsevier

    Rob Lambkin-Williams

  16. The Threat of Avian Influenza H5N1: 'Do We Have the Tools for the Job?'

    Article • Antiviral Chemistry and Chemotherapy, April 2007, SAGE Publications

    Rob Lambkin-Williams

  17. Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection

    Article • BMJ Open Respiratory Research, January 2007, Springer Science + Business Media

    Rob Lambkin-Williams

  18. Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine

    Article • Vaccine, October 2004, Elsevier

    Dr Christian Herzog, Rob Lambkin-Williams

  19. FluINsure™, an inactivated trivalent influenza vaccine for intranasal administration, is protective in human challenge with A/Panama/2007/99 (H3N2) virus

    Article • International Congress Series, June 2004, Elsevier

    Rob Lambkin-Williams

  20. Associations between Human Leukocyte Antigens and Nonresponsiveness to Influenza Vaccine

    Article • The Journal of Infectious Diseases, January 2002, Oxford University Press (OUP)

    Rob Lambkin-Williams